0001601830-24-000022.txt : 20240308 0001601830-24-000022.hdr.sgml : 20240308 20240308190851 ACCESSION NUMBER: 0001601830-24-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibson Christopher CENTRAL INDEX KEY: 0001856369 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40323 FILM NUMBER: 24736167 MAIL ADDRESS: STREET 1: C/O RECURSION PHARMACEUTICALS STREET 2: 41 S. RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (385) 269-0203 MAIL ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 4 1 wk-form4_1709942921.xml FORM 4 X0508 4 2024-03-06 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856369 Gibson Christopher C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 1 0 0 Chief Executive Officer 0 Class A Common Stock 2024-03-06 4 C 0 10000 0 A 1114919 D Class A Common Stock 2024-03-06 4 G 0 10000 0 D 1104919 D Class A Common Stock 2024-03-06 4 M 0 31250 2.48 A 1136169 D Class A Common Stock 2024-03-06 4 M 0 8674 11.40 A 1144843 D Class A Common Stock 2024-03-06 4 S 0 36319 11.8583 D 1108524 D Class A Common Stock 2024-03-06 4 C 0 4000 0 A 4000 I by LAHWRAN-3 LLC Class A Common Stock 2024-03-06 4 S 0 4000 11.5648 D 0 I by LAHWRAN-3 LLC Class A Common Stock 2024-03-06 4 C 0 20000 0 A 20000 I By LAHWRAN-4 LLC Class A Common Stock 2024-03-06 4 S 0 20000 11.5501 D 0 I By LAHWRAN-4 LLC Class A Common Stock 2024-03-06 4 C 0 1000 0 A 1000 I by Gibson Family Trust Class A Common Stock 2024-03-06 4 S 0 1000 11.5621 D 0 I by Gibson Family Trust Stock Option (Right to Buy) 2.48 2024-03-06 4 M 0 31250 0 D 2030-12-30 Class A Common Stock 31250 312500 D Stock Option (Right to Buy) 11.40 2024-03-06 4 M 0 8674 0 D 2032-02-04 Class A Common Stock 8674 399002 D Class B Common Stock 0 2024-03-06 4 C 0 10000 0 D Class A Common Stock 10000 6461496 D Class B Common Stock 0 2024-03-06 4 C 0 4000 0 D Class A Common Stock 4000 511000 I by LAHWRAN-3 LLC Class B Common Stock 0 2024-03-06 4 C 0 20000 0 D Class A Common Stock 20000 388000 I by LAHWRAN-4 LLC Class B Common Stock 0 2024-03-06 4 C 0 1000 0 D Class A Common Stock 1000 117875 I by Gibson Family Trust Stock Option (Right to Buy) 8.55 2033-02-01 Class A Common Stock 0 813600 D Stock Option (Right to Buy) 11.40 2022-02-04 2032-02-04 Class A Common Stock 0 5436 D Stock Option (Right to Buy) 10.09 2034-02-09 Class A Common Stock 0 666898 D This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022. Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $11.24 to $12.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Represents the conversion of Class B Common Stock into Class A Common Stock. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. This transaction was executed in multiple trades at prices ranging from $11.32 to $12.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. This transaction was executed in multiple trades at prices ranging from $11.22 to $12.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. This transaction was executed in multiple trades at prices ranging from $11.23 to $12.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. /s/ Jonathan Golightly, attorney-in-fact 2024-03-08